Angiotensin II Receptor Blockers (ARBs)
Angiotensin II receptor blockers (ARBs) are newer blood pressure medicines that block a chemical (angiotensin II) that normally causes blood vessels to narrow. By blocking the effects of angiotensin II, ARBs cause blood vessels to relax, which can lower blood pressure. ARBs may also be used to treat congestive heart failure and kidney damage from diabetes (diabetic nephropathy), or improve survival following a heart attack.
Some examples of ARBs include:
- Azilsartan (Edarbi™) or azilsartan/chlorthalidone (Edarbyclor™)
- Candesartan (Atacand®) or candesartan-hydrochlorothiazide (Atacand HCT®)
- Eprosartan (Teveten®) or eprosartan-hydrochlorothiazide (Teveten® HCT)
- Irbesartan (Avapro®) or irbesartan-hydrochlorothiazide (Avalide®)
- Losartan (Cozaar®) or losartan-hydrochlorothiazide (Hyzaar®)
- Olmesartan (Benicar®), olmesartan-hydrochlorothiazide (Benicar HCT®), or amlodipine and olmesartan (AZOR™)
- Telmisartan (Micardis®) or telmisartan-hydrochlorothiazide (Micardis® HCT)
- Valsartan (Diovan®) or valsartan-hydrochlorothiazide (Diovan HCT®).
Anticoagulants decrease the ability of the blood to clot and, therefore, help to prevent clots from forming in your arteries and blocking blood flow. (These medicines are sometimes called "blood thinners," though they do not actually thin the blood.) Anticoagulants will not dissolve clots that have already formed, but they may prevent the clots from becoming larger and causing more serious problems.